Search research articles
Contact Us
Filters
Showing results (351-360 of 361) with videos related to
Page
of 37
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2014
Prostate cancer, version 2.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications
|
September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
The Journal of Clinical Investigation
|
June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancer
Zhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell
|
October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 361) with videos related to
Sort By:
Page
of 37
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2014
Prostate cancer, version 2.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Nature Communications
|
September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
The Journal of Clinical Investigation
|
June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancer
Zhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell
|
October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Page
of 37